voxeljet To Raise $10M Via Institutional Equity Offering At 26% Discount
3D printing company voxeljet AG (NASDAQ:VJET) priced 1.1 million shares at $8.88 (€7.52) per share in a secondary institutional equity offering.…
Hong Kong’s Prenetics Announces $1.3B SPAC Merger
Citing sources close to the deal, CNBC reports that a Hong Kong biotech Prenetics is set to merge with Artisan Acquisition…
voxeljet Shares Fall As It Seeks To Raise €1.8M Via Secondary Equity Offering
Industrial 3D printing system company voxeljet AG (NASDAQ:VJET) proposed to raise €1.77 million via a secondary equity offering. It will utilize the…
Belden Raises €300M Via Private Offering Of 3.375% Senior Subordinated Notes
Belden Inc. (NYSE:BDC) has priced the private offering of €300 million in aggregate principal amount of 3.375% senior subordinated notes due…
Shoals Technologies Raises $235M Via Secondary Equity Offering At 1.4% Discount
Shoals Technologies Group, Inc (NASDAQ:SHLS) priced 13.4 million shares at $28 per share in a secondary public offering. The offer price…
Immunic Stock Is Trading Lower After Equity Raise Of $45M To Fund Lead Pipeline Candidates
Immunic Inc (NASDAQ:IMUX) has priced an underwritten public offering of 4.5 million shares at $10 per share, representing a discount…
Marin Software Says Entered Into Equity Distribution Agreement With JMP Securities For Offering Of Up To $40M
On July 15, 2021, Marin Software Incorporated (the “Company”) entered into an Equity Distribution Agreement (the “Equity Distribution Agreement”) with JMP Securities LLC (the “Placement
Gatos Silver Announces Pricing Of Public Offering Of 8.93M Shares At $14/Share
Gatos Silver, Inc. (TSX:GATO) ("Gatos Silver") today announced the pricing of a public offering of 8,930,000 shares of common stock by Gatos Silver and 2,500,000 shares of common stock by certain selling
Immunic Announces Pricing Of $45M Public Offering Of 4.5M Shares Of Common Stock
Immunic, Inc. (the "Company") (NASDAQ:IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune
Dogness Announces Entry into Agreement For Registered Direct Offering Of Approximately $3.96 Million Class A Common Shares; 12,178,120 Shares At $1.82/Share
Dogness (International) Corporation ("Dogness" or the "Company") (NASDAQ:DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today